Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Procept (PRCT): 50% rise on high volume. Why? -- Ignore unavailable to you. Want to Upgrade?

To: Douglas who wrote (292)	11/13/1997 11:09:00 AM
From: Douglas	Read Replies (1) \| Respond to of 455

Reference Msg. #288: I highly recommend that any readers e-mail the British Medical Research Council. Their MRC News magazine is highly informative and it's free. It took less than a week to receive. Send them your address and ask to be added to their mailing list. The latest issue does mention Procept in a postive tone. Again, I wonder why Procept hasn't used the article in some sort of press release. Researchers love to get published! Their internet address is: nimr.mrc.ac.uk (the bottom left corner has the e-mail icon)

To: Douglas who wrote (292)	11/16/1997 3:36:00 PM
From: Daniel Shaffer	Read Replies (1) \| Respond to of 455

What Else is in the Pipeline? Thanks for your well-informed reply, Douglas. I can't recall the source, but I heard that there is a close relationship between PRCTD and Harvard Medical School. Maybe they are using faculty as consultants, med. students as interns, etc. At any rate, it strikes me odd that they should have so little trouble raising capital privately unless they are disclosing information and/or showing other products in the pipeline to those institutional investors that they are not showing to their own stockholders. Is that legal? > Couldn't find any reference to pay cuts! > Stanley C. Erck 1996 $231,000 > Michael J. Higgins 1996 $102,000" Pay is probably not out of line, but I'd feel a lot better if there were big equity "carrots" for these guys. > Stock ownership is too little: > All current executive officers and directors as a group > 7 persons............................469,074(before split) 2.3% It is very disturbing that the upper management and directors have so little to lose in terms of an equity stake. If I were involved in a new venture about which I was truly optimistic, I would be acquiring stock at the current prices. The potential capital gains could be enormous, if...... This company is a real puzzle to me. Is it that their PR is so lousy or that they just don't have much to say. The latter just doesn't jive with their capability of attracting new capital. Every struggling start-up that I've seen close-hand has found it extremely difficult to impossible to attract new capital when they are running out of money short of having a hot product on the market! Best wishes!